Gentamicin was measured in the presence of clindamycin by using as the assay organism a strain of Staphylococcus aureus that was resistant to clindamycin; clindamycin was measured in the presence of gentamicin by using Clostridium perfringens as the assay organism. Both assays were in agar diffusion systems, were rapid (2 to 4 h), and had errors of less than 10%. Neither antibiotic antagonized or synergized with the other against a variety of organisms. The pK of clindamycin was 7.3, and the pK of gentamicin was 8.2. Gentamicin was 100 or more times as active in alkaline medium against both gram-positive and gram-negative organisms, but clindamycin showed a striking pH effect on activity only with gram-positive organisms.
The increasing awareness of the occurrence of infections due to anaerobic organisms has led to more frequent use of antibiotics with activity against bacteroides and other anaerobic organisms, often in combination with other antibiotics. Because clindamycin has been shown to have activity at low concentration against most anaerobic bacteria studied (3) , it is often used in combination with gentamicin or kanamycin in treating a variety of infections that follow perforation of the bowel or leakage of intestinal contents; such conditions obviously seed the soiled spaces with both anaerobic organism and the aerobic enterobacteriaceae.
It is obviously desirable to know whether clindamycin antagonizes, enhances, or has no effect at all on the antibacterial activity of gentamicin, and also whether gentamicin alters the activity of clindamycin against organisms within its spectrum. Ultimately, this question should be studied in animals, but in this paper that question is examined in vitro.
An additional problem arising from the use of these antibiotics in combination is in measuring each in blood or other body fluids. It has been pointed out that for antibiotics such as the aminoglycosides, for which toxic and therapeutic levels are relatively close, measurement of antibiotic concentrations in blood is desirable, even when there is no gross organ dysfunction or obvious therapeutic failure, to be sure that 54 therapeutic levels are achieved and toxic levels avoided (7, 8) . Thus, a convenient method for measuring gentamicin in the presence of clindamycin is desirable and is described here.
The measurement of clindamycin in the presence of gentamicin is unlikely to be required very often for the practical management of patients, as described above, because clindamycin is so relatively nontoxic and the desired therapeutic levels are so very much lower than what is thought to be toxic. Nonetheless, there are instances when a technique for measuring clindamycin in the presence of gentamicin is desired (as in studying the pharmacokinetics of clindamycin in various clinical and laboratory situations), and such a technique is presented here.
(This paper was presented in part at the Thirteenth Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., September 1973).
MATERIALS AND METHODS
Techniques for measuring gentamicin in the presence of clindamycin. An agar diffusion technique was used, essentially as previously described (7, 8, 9) but utilizing as the assay organism Staphylococcus aureus PSTEML that was (and is) resistant to penicillin, streptomycin, tetracycline, erythromycin, methicillin, lincomycin, and clindamycin when originally isolated from a patient in Denmark; it was kindly supplied by Per Billow. S. aureus PSTEML on October 25, 2017 by guest http://aac.asm.org/ Downloaded from was grown 18 h at 37 C in brain heart infusion (BHI) broth (Difco), which was used as the stock culture for inoculating (1%, vol/vol) antibiotic assay medium no. 5 (Difco) (at pH 8) when the assay medium was molten, and at approximately 48 to 50 C. A 5-ml portion of the seeded assay medium was poured into each 100 by 15 ml plastic Petri dish (Falcon Plastics). These were permitted to harden on a level bench, after which they were either used for assays or stored in sealed plastic bags (to prevent dehydration) for use over the following week. The stock culture was kept at 4 C and was suitable for seeding the assay agar after 1 to 3 weeks of refrigeration. The standards of gentamicin were prepared at 12, 6, and 1.5,ug/ml in a fluid as nearly identical as possible to that of the fluid in which the unknown concentration was dissolved (e.g., in human serum if the unknown was in serum and in heparinized plasma if the unknown was in heparinized plasma). Two assay plates were required for each unknown sample to jg/ml may be used. As in all agar diffusion assays, it is essential that the fluid containing the standard concentrations be as nearly identical as possible to that containing the unknown, especially in regard to pH and protein content.
Once the standard and unknown fluids had been loaded onto their paper disks, the disks were transferred to the assay plates and tapped in contact with the surface with metal forceps. After the lids were placed on the assay plates, they were placed in a Brewer Anaerobic Jar (BBL) and left at room temperature until anaerobiasis was achieved (with the GasPak system), as indicated by the methylene blue indicator turning white; this takes about 1 h. The jar was then placed on a level shelf at 37 C for 1 to 3 h (or overnight if that is most convenient) after which the zones of inhibition-which are very easy to read because there is no hemolysis there-could be measured with calipers.
The values were calculated in the usual way for agar diffusion assays, as suggested.
Most serum samples contain higher concentrations and must be diluted (or else higher standards must be used).
Antibacterial activity of clindamycin and gentamicin alone and in combination. The Steers replica inoculator (12) 
RESULTS
Assay of gentamicin in the presence of clindamycin. The error in the assay was < 10%. A typical standard curve is shown in Fig. 1 (Table 3) . The antibacterial activity of gentamicin was also greatest at alkaline pH. Against aerobic gram-negative bacilli there was a 100-to 200-fold decrease in MIC at pH 8.5 compared with activity at pH 5.5 (Table 4) , with most of the change (40-to 130-fold effect) occurring between pH 5.5 and 7.4. The pH effect on activity against staphylococci also occurred mainly between pH 5.5 and 7.4, with only a twofold (at most) change occurring between pH 7.4 and 8.5 (Table 4) .
When varying amounts of clindamycin and gentamicin were combined and their antibacterial activity was determined, there was neither clear-cut synergy nor antagonism for the bacteristatic effect.
Ionization of clindamycin and gentamicin. On titration between pH 4.0 and pH 9.0 one equivalent of clindamycin becomes un-ionized, with a pK of 7.3 (Fig. 3) . Between pH 5 and pH 11, three equivalents of gentamicin become un-ionized as a single smooth curve with a pK of 8.2 (Fig. 4) .
DISCUSSION
The two agar diffusion assays described are both quite simple and require neither special reagents nor equipment not generally present in ordinary hospital clinical bacteriology laboratories. We are not aware of another assay for clindamycin in the presence of gentamicin, although the general principle has been widely suggested and used, i.e., assay with an organism "sensitive" to the antibiotic to be measured and "resistant" to the other. The assay described here for gentamicin in the presence of clindamycin is also based upon that same principle; a similar assay has been reported previously by Alcid and Seligman (2) . For routine assay of gentamicin-either by itself or with a f3-lactam antibiotic-it has been simpler to use Bacillus subtilis spores because (i) the poured plates give rapid results even after 14 days of storage (as opposed to 3 days with the S. aureus), (ii) pouring plates seeded with B. subtilis spores is less prone to the problem of hot agar killing vegetative bacteria, and (iii) the plates poured with B. subtilis can also be used for the assay of kanamycin, streptomycin, neomycin, tobramycin, or vancomycin (7, 8, 9) .
The antimicrobial activity of clindamycin at pH 7.4 described here is similar to what others have reported (3), with minimal activity (high MICs) against aerobic gram-negative bacilli and very great activity (low MICs) against gram-positive cocci. Although there is a very clear relationship between ionization and activity (Fig. 3) , it is noteworthy that large changes 3. --against many species of enterobacteriaceae at alkaline pH (6, 9, 10), a finding that has practical clinical application (4, 12) , clindamycin's activity against the enterobacteriaceae is only minimally enhanced at alkaline pH. Therefore, it does not seem likely that clindamycin will be useful in some urinary tract infections, as has been the case with erythromycin (4, 12) .
Gentamicin is also a basic antibiotic with greater activity at alkaline pH. As was the case with clindamycin, the greatest change in antibacterial activity occurred below the pK, 8.3 in this case. Although three equivalents of gentamicin ionize as a single smooth curve (Fig. 4) , it thus appears that antibacterial activity is virtually independent of the charge on the last (strongest) group to titrate.
The observation here that gentamicin and clindamycin neither enhanced nor antagonized the activity of the other against the organisms tested suggests that there may be no objection to using them together in treating patients with bowel perforations. However, others have reported some antagonism of these antibiotics against bacteroides in vitro (5). Additional in vitro as well as in vivo observations on this point would be helpful. (1) .
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